Sunday, January 18, 2026

Latest

Trulieve: Analysts Expect Beat On Company Full Year Guidance

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their fourth quarter and year-end financials pre-market on March 23rd. Analysts have a consensus C$65.83 12-month price target on the company, via a total of 14 analysts, with two analysts have strong buy ratings and the other 12 have buy ratings. The street high comes from Stifel-GMP with a C$107 price target, and the lowest target comes from Echelon Wealth with a C$43 price target.

Twelve analysts have revenue estimates for the fourth quarter. The mean between all 12 is U$162.49 million; this number has been revised upwards from U$159.35 million at the start of the year. Stifel-GMP currently has the highest revenue estimate with U$170.87 million, while the lowest comes from PI Financial with a U$153.25 estimate.

For the full year, management has guided for revenues between U$465 – U$485 million, but the average estimate between 14 analysts is currently U$513.59 million. This number has been revised upwards from U$511.55 million at the start of the year. The street high comes from Stifel-GMP with a U$523.95 full-year revenue estimate.

Onto EBITDA estimates, there are currently 12 analysts who have fourth-quarter EBITDA estimates. The mean is currently U$75.56 million, with this number being revised upwards from U$72.46 million at the start of the year. Street high goes to Needham with a U$81.30 million EBITDA estimate and the lowest being PI Financial with a U$68.87 million estimate.

For the full-year management has also provided guidance for EBITDA in the range of U$205 – U$225 million. The current EBITDA means across 13 analysts is U$252.47 million, with that number basically staying flat year-to-date. Needham currently has the highest full-year estimate at U$258.80 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Dolly Varden Silver: The Contango ORE Merger

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Recommended

NexGen Launches 42,000 Metre Drill Program At PCE While Expanding Mineralized Footprint

First Majestic Hits 2025 Guidance, Producing 31.1 Million Silver Equivalent Ounces, Increases Dividend

Related News

Trulieve Reports Fourth Quarter Revenues Of $US79.7 Million

Trulieve Cannabis (CSE: TRUL) reported its fourth quarter and full fiscal year 2019 financial results...

Wednesday, April 8, 2020, 08:39:35 AM

Trulieve Reports Revenue Of $193.8 Million, Net Income Of $30.1 Million For Q1 2021

Trulieve Cannabis Corp (CSE: TRUL) this morning reported its first quarter 2021 financial results this...

Thursday, May 13, 2021, 07:21:23 AM

Trulieve Loses Foreign Private Issuer Status, Must Transition To US GAAP Reporting Standards

Evidently, recent buying activity in Trulieve Cannabis Corp (CSE: TRUL) has come largely from South...

Tuesday, July 14, 2020, 09:16:53 AM

Trulieve Cannabis: Analyst Q1 Consensus Estimates

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their first quarter financials before...

Wednesday, May 12, 2021, 04:01:00 PM

Trulieve Posts $224.1 Million In Q3 Revenues, Positive Net Income

Trulieve Cannabis (CSE: TRUL) this morning reported its third quarter financial results for 2021. The...

Monday, November 15, 2021, 07:30:59 AM